InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: None

Wednesday, 06/05/2019 5:38:44 PM

Wednesday, June 05, 2019 5:38:44 PM

Post# of 426450
Why Drug Reps probably won't be cost effective (links with recent data)

https://www.bluenovius.com/healthcare-marketing/pharma-sales-reps-struggling/

Doctors apparently get 2800 requests to see them a year on average, most refuse to see most or nearly all of them and the average time they will see them if they do is about two minutes. According to JL they are very limited as to what "incentives" they can give to doctors anymore. Doctors are overloaded with both paperwork and sales calls, drug reps will in most cases be treated as "spammers".

https://www.healthleadersmedia.com/strategy/sales-reps-may-be-wearing-out-their-welcome-operating-room (deals with device reps but very similar issues)

AMRN's marketing money would be better spent on direct to consumer marketing once they get the label. Normally all those drug commercials have a list of horrible side effects... we shouldn't have that problem.

People will "ask their doctor about Vascepa".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News